// App-Quantinova.ai

7002 : Optimizing Chimeric Antigen Receptor (CAR)T Cell Therapy for Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Noelle V. Frey

Principal Investigators

  • Pamela A Shaw

  • Elizabeth O. Hexner

  • Saar Gill

  • Katherine Marcucci

  • Selina M. Luger

  • James K. Mangan

  • Stephan A. Grupp

  • Shannon L. Maude

  • Solveig Ericson

  • Bruce Levine

  • Simon F. Lacey

  • Jan J. Melenhorst

  • Carl H. June

  • David L. Porter

Medical Centers

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

  • University of Pennsylvania, Philadelphia, PA

  • University of Pennsylvania, Translational Research Program, Philadelphia, PA

  • Childrens Hospital of Philadelphia, Philadelphia, PA

  • Novartis, East Hanover, NJ

  • Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 2AP

  • Coxsackie Virus And Adenovirus Receptor

  • Twist-related protein 1

Drug/Treatment

  • CTL019

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01029366

  • NCTL019

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved